Fusion Pore
Introduction
Exocytosis is a universal process of eukaryotic cells. This activity of cells consists of fusion between the plasma membranes and the vesicle, leading to the formation of a fusion pore. Fusion pore is the aqueous pathway by which molecules leave a vesicle and move out into the surrounding extracellular region. A fusion pore is relatively narrow. However, when it forms, it can expand to allow the vesicle membrane to merge with the plasma membrane. As shown in Figure 1, state 2b could be regarded as a closed fusion pore, which could open to a proteinaceous pore (state 3). A lipidic fusion pore (state 5) is an essential intermediate in any model of membrane fusion.
Fig.1 Putative intermediates of membrane fusion and their transitions. (Chang, 2017)
Transport Properties
Fusion pore provides a conduit for transport, and most of what we know about fusion pore derives from measurements of some form of flux. The transport of signaling molecules, ions, and membranes can be measured and used to gain insight into fusion pore structure and composition. Besides, it has been reported that patch clamp measurements of conductance and amperometry measurements of content flux could be used to illustrate successive stages of membrane fusion.
Composition and Structure
Secretion of neurotransmitters via exocytotic fusion pores is extremely necessary for synaptic transmission. Unfortunately, the ephemeral nature of fusion pores has severely limited efforts to study their composition and structure. During the past ten years, two asymmetric types of fusion pores have been observed.
- Rim-pores formed at the rim of a single membrane thick hemi-fusion diaphragm
- Vertex fusion pores formed at the edge or vertex of the contact zone formed during protein-mediated docking and adhesion of membranes
Efforts in structure research have also never ceased. Scientists developed an assay in which nanodiscs bearing v-SNAREs fuse with small unilamellar vesicles (SUVs) containing t-SNAREs, in a manner accelerated by Ca2+ and synaptotagmin-1. Finally, the study reveals that the fusion pore is formed by a combination of lipids and SNARE transmembrane domains.
Figure 2 The nanodisc-SUV fusion system to study fusion pores. (Bao, 2016)
Newly Research
In 2021, the scientist presented an in vitro method and studied the initial phase of vesicle fusion by three-dimensional (3D) microfluidic chip. They monitored the fusion of small vSNARE-decorated vesicles with a suspended asymmetric membrane containing tSNAREs and having the same lipid composition as a typical plasma membrane. Scientists finally identified three fusion pore stages: two reversible phases in which the fusion pore has an apparent diameter of 0.4 ± 0.1 nm and 0.8 ± 0.2 nm, and an irreversible phase above 1.5 nm where the fusion pore expands continuously and indefinitely.
For customized fusion pore related products, please feel free to contact us for cooperation.
References
- Chang, C. W. Fusion pores and their control of neurotransmitter and hormone release. Journal of General Physiology. 2017, 149(3): 301-322.
- Bao, H.; et al. Exocytotic fusion pores are composed of both lipids and proteins. Nature structural & molecular biology. 2016, 23(1): 67.
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Anti-ApoC3 BBB Shuttle Antibody (NRZP-1022-ZP3503) (Cat#: NRZP-1022-ZP3503)
- iNeuMab™ Anti-FGFR1 Antibody (NRP-0422-P1244) (Cat#: NRP-0422-P1244)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2275) (Cat#: NRP-0422-P2275)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1760) (Cat#: NRP-0422-P1760)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1683) (Cat#: NRP-0422-P1683)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- iNeuMab™ Anti-TREM2 Antibody (NRP-0422-P792) (Cat#: NRP-0422-P792)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Anti-GARP Antibody (NRP-0422-P1639) (Cat#: NRP-0422-P1639)
- Rat Muller Cell (Cat#: NCL2110P040)
- iNeu™ Human Neural Stem Cell Line (Cat#: NCL200552ZP)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- Human Microglia Cell Line HMC3, Immortalized (Cat#: NCL-2108P38)
- Green Fluorescent Tau cell Line (Cat#: NCL2110P219)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- Green Fluorescent Alpha-synuclein Cell Line (Cat#: NCL2110P209)
- Mouse Glioma Cell Line GL261-GFP (Cat#: NCL-2108P04)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)